Interventional Cardiology Devices Market Forecasts to 2028 – Global Analysis By Product (Structural Devices, Angioplasty Stents, Catheters, Hemodynamic Flow Alteration Devices, Angioplasty Ballons, Plaque Modification Devices, Inferior Vena Cava (IVC) Fil

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,150	175 Pages	Stratistics Market Research Consulting	May, 2023	SMR17938973

Best Price Guarantee
Price	from $4,150
Length	175 Pages
Publisher	Stratistics Market Research Consulting
Published Date	May, 2023
SKU	SMR17938973

Interventional Cardiology Devices Market Forecasts to 2028 – Global Analysis By Product (Structural Devices, Angioplasty Stents, Catheters, Hemodynamic Flow Alteration Devices, Angioplasty Ballons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Other Products), End User (Ambulatory Surgical Centers, Hospitals, Other End Users) and Geography

According to Stratistics MRC, the Global Interventional Cardiology Devices Market is accounted for $17.5 billion in 2022 and is expected to reach $30.4 billion by 2028 growing at a CAGR of 9.7% during the forecast period. Specialised equipment is needed for interventional operations in order to treat restricted arteries, damaged or weakened vessels, or other impacted areas of the heart anatomy without the need for surgery. As a result, cardiac catheterization laboratories or hospitals utilise interventional cardiology tools including coronary stents, cutting balloon catheters, and percutaneous transluminal coronary angioplasty (PTCA) to undertake minimally invasive procedures.

According to the results published in the journal of Annals of Thoracic Surgery, 2020, approximately a 53% decrease in the total cardiac surgery volume was observed in the United States in 2020 relative to 2019, a major reason of which was the COVID-19 pandemic.

Market Dynamics:

Driver:

Rising tobacco consumption and increasing incidence of obesity

Cardiovascular disorders are distinctly correlated with smoking and obesity. Smoking makes blood vessels more likely to develop plaque. Smoke from cigarettes contains chemicals that make blood thicken and clot in veins and arteries. When the arteries that provide blood to the heart are constricted by plaque or clogged by clots, coronary heart disease develops. Because of this, smokers are considerably more likely than non-smokers to acquire CAD. Thus, it is anticipated that the demand for cardiovascular devices, especially interventional cardiology equipment, would rise in the coming years as a result of cigarette smoking and obesity.

Restraint:

Complications of Interventional Cardiology procedures

Blood clots forming around the stent are known as stent thrombosis. Restenosis: The return of stenosis (abnormal arterial narrowing) following corrective surgery, and as some of the stents are metallic, an MRI scan cannot be done. The complications listed above are linked to interventional cardiac procedures. The development of the worldwide market for interventional cardiology devices is anticipated to be hampered by complications related to interventional cardiology operations.

Opportunity:

Rising Number of Product Launches by Key Players

The leading players' increasing product introductions are projected to fuel the market for interventional cardiology devices. The significant prevalence of cardiovascular conditions including valvar defects and atrial stenosis in developing countries like China, India, and Brazil has resulted in a large need for interventional cardiology equipment for treatment. Major players are increasingly collaborating to carry out a number of clinical trials on interventional devices.

Threat:

Stringent and complex standards

The challenging regulatory requirements for medical device affiliation are changed to accommodate shifting consumer expectations. The legal ramifications of these restrictions make them challenging. To maintain public safety, performance and quality of medical devices must be closely inspected. Therefore, the complicated and strict criteria employed to approve medical equipment may restrict market expansion.

Covid-19 Impact

The market was significantly impacted by the COVID-19 epidemic. Worldwide elective surgical operations were greatly impacted by COVID-19, which also had a huge impact on the worldwide market. Treatments for structural and coronary heart disease were delayed while medical institutions battled an influx of individuals with COVID-19 infection.

The Drug Eluting Stents segment is expected to be the largest during the forecast period

The Drug Eluting Stents segment is estimated to have a lucrative growth. Drug-eluting stents are used to assist stop the development of scar tissue in the arterial lining by coating them with medicine that is gradually released. By keeping the artery smooth and wide open, this promotes healthy blood flow. These stents perform better than self-expanding & balloon-expanding stents and are typically utilised for the lower extremities. Therefore, it is anticipated that the acceptance of cutting-edge cardiovascular therapies and the development of drug-eluting stent technology would be the main factors driving the segment's growth. The drug-eluting stents sector is therefore anticipated to increase strongly throughout the projected period as a result of the aforementioned causes.

The Hospitals segment is expected to have the highest CAGR during the forecast period

The Hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period owing to the hospital operations have a high success rate. Less than 6% of people who have a cardiac arrest outside of a hospital survive, compared to over 200,000 cardiac arrests each year in hospitals where 24% of patients do.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to rising consumption of unhealthy foods in emerging nations, which is predicted to accelerate the expansion of the market for interventional cardiology devices. The administrations in the area are fervently striving to organise a plethora of initiatives, programmes, and campaigns to educate the populace about cardiovascular illnesses and their impact on life in order to address the problem.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to region's advanced healthcare infrastructure, supportive government product development initiatives, high patient awareness levels, and expanding target patient population. Because North America can support a high rate of medical device innovation and has a high rate of consumption of expensive interventional cardiology equipment, it dominates the market under investigation. A few significant market participants in the area are also creating innovative goods and technologies to compete with already available goods, while others are purchasing and collaborating with the other trending businesses in the industry.

Key players in the market

Some of the key players profiled in the Interventional Cardiology Devices Market include Philips, Merck KGAA, Thermo Fisher Scientific, Inc., Boston Scientific, Abbott, Medtronic, Edwards Lifesciences Corporation, Koninklijke Philips N.V., iVascular , Biosensors International Group , Cardinal Health and Terumo Corporation.

Key Developments:

In December 2022, Boston Scientific Corporation acquired a majority of share in Acotec Scientific Holdings. The acquisition will help Boston Scientific Corporation to expand its product portfolio and market in China.

In February 2021, iVascular announced the launch of new lengths for the Angiolite drug-eluting stent (DES) for the treatment of long lesions in the coronary arteries. The 44- and 49-mm lengths received the European CE Mark approval for the treatment of diffuse lesions.

Products Covered:
• Structural Devices
• Guidewires
• Angioplasty Stents
• Catheters
• Hemodynamic Flow Alteration Devices
• Angioplasty Ballons
• Plaque Modification Devices
• Inferior Vena Cava (IVC) Filters
• Accessories
• Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
• Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
• Other Devices
• Other Products

End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary
2 Preface: 2.1 Abstract; 2.2 Stake Holders; 2.3 Research Scope; 2.4 Research Methodology; 2.4.1 Data Mining; 2.4.2 Data Analysis; 2.4.3 Data Validation; 2.4.4 Research Approach; 2.5 Research Sources; 2.5.1 Primary Research Sources; 2.5.2 Secondary Research Sources; 2.5.3 Assumptions
3 Market Trend Analysis: 3.1 Introduction; 3.2 Drivers; 3.3 Restraints; 3.4 Opportunities; 3.5 Threats; 3.6 Product Analysis; 3.7 End User Analysis; 3.8 Emerging Markets; 3.9 Impact of Covid-19
4 Porters Five Force Analysis: 4.1 Bargaining power of suppliers; 4.2 Bargaining power of buyers; 4.3 Threat of substitutes; 4.4 Threat of new entrants; 4.5 Competitive rivalry
5 Global Interventional Cardiology Devices Market, By Product: 5.1 Introduction; 5.2 Structural Devices; 5.2.1 Aortic Valve Therapy Devices; 5.2.2 Other Therapy Devices; 5.2.1.1 Tricuspid Vvalve; 5.2.1.2 Left Atrial Appendage Therapy Devices; 5.2.1.3 Pulmonary Valve; 5.2.1.4 Mitral Valve; 5.3 Guidewires; 5.4 Angioplasty Stents; 5.4.1 Bare Mental Stents; 5.4.2 Drug Eluting Stents; 5.4.3 Bioabsorbable Stents; 5.5 Catheters; 5.5.1 IVUS/OCT Catheters; 5.5.2 Angiography Catheters; 5.5.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters; 5.6 Hemodynamic Flow Alteration Devices; 5.6.1 Chronic Total Occlusion Devices; 5.6.2 Embolic Protection Devices; 5.7 Angioplasty Ballons; 5.7.1 Drug Eluting Ballons; 5.7.2 Old/ Normal Ballons; 5.7.3 Cutting & Scorimg Ballons; 5.8 Plaque Modification Devices; 5.8.1 Thrombectomy Devices; 5.8.2 Atherectomy Devices; 5.9 Inferior Vena Cava (IVC) Filters; 5.10 Accessories; 5.11 Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires; 5.12 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons; 5.13 Other Devices; 5.13.1 Ballon Inflation Devices; 5.13.2 Vascular Closure Devices; 5.13.3 Hemostasis Valves; 5.13.4 Introducer Sheaths; 5.14 Other Products
6 Global Interventional Cardiology Devices Market, By End User: 6.1 Introduction; 6.2 Ambulatory Surgical Centers; 6.3 Hospitals; 6.4 Other End Users
7 Global Interventional Cardiology Devices Market, By Geography: 7.1 Introduction; 7.2 North America; 7.2.1 US; 7.2.2 Canada; 7.2.3 Mexico; 7.3 Europe; 7.3.1 Germany; 7.3.2 UK; 7.3.3 Italy; 7.3.4 France; 7.3.5 Spain; 7.3.6 Rest of Europe; 7.4 Asia Pacific; 7.4.1 Japan; 7.4.2 China; 7.4.3 India; 7.4.4 Australia; 7.4.5 New Zealand; 7.4.6 South Korea; 7.4.7 Rest of Asia Pacific; 7.5 South America; 7.5.1 Argentina; 7.5.2 Brazil; 7.5.3 Chile; 7.5.4 Rest of South America; 7.6 Middle East & Africa; 7.6.1 Saudi Arabia; 7.6.2 UAE; 7.6.3 Qatar; 7.6.4 South Africa; 7.6.5 Rest of Middle East & Africa
8 Key Developments: 8.1 Agreements, Partnerships, Collaborations and Joint Ventures; 8.2 Acquisitions & Mergers; 8.3 New Product Launch; 8.4 Expansions; 8.5 Other Key Strategies
9 Company Profiling: 9.1 Philips; 9.2 Merck KGAA; 9.3 Thermo Fisher Scientific, Inc.; 9.4 Boston Scientific; 9.5 Abbott; 9.6 Medtronic; 9.7 Edwards Lifesciences Corporation; 9.8 Koninklijke Philips N.V.; 9.9 iVascular; 9.10 Biosensors International Group; 9.11 Cardinal Health; 9.12 Terumo Corporation
List of Tables: Table 1 Global Interventional Cardiology Devices Market Outlook, By Region (2020-2028) ($MN); Table 2 Global Interventional Cardiology Devices Market Outlook, By Product (2020-2028) ($MN); Table 3 Global Interventional Cardiology Devices Market Outlook, By Structural Devices (2020-2028) ($MN); Table 4 Global Interventional Cardiology Devices Market Outlook, By Aortic Valve Therapy Devices (2020-2028) ($MN); Table 5 Global Interventional Cardiology Devices Market Outlook, By Other Therapy Devices (2020-2028) ($MN); Table 6 Global Interventional Cardiology Devices Market Outlook, By Tricuspid Vvalve (2020-2028) ($MN); Table 7 Global Interventional Cardiology Devices Market Outlook, By Left Atrial Appendage Therapy Devices (2020-2028) ($MN); Table 8 Global Interventional Cardiology Devices Market Outlook, By Pulmonary Valve (2020-2028) ($MN); Table 9 Global Interventional Cardiology Devices Market Outlook, By Mitral Valve (2020-2028) ($MN); Table 10 Global Interventional Cardiology Devices Market Outlook, By Guidewires (2020-2028) ($MN); Table 11 Global Interventional Cardiology Devices Market Outlook, By Angioplasty Stents (2020-2028) ($MN); Table 12 Global Interventional Cardiology Devices Market Outlook, By Bare Mental Stents (2020-2028) ($MN); Table 13 Global Interventional Cardiology Devices Market Outlook, By Drug Eluting Stents (2020-2028) ($MN); Table 14 Global Interventional Cardiology Devices Market Outlook, By Bioabsorbable Stents (2020-2028) ($MN); Table 15 Global Interventional Cardiology Devices Market Outlook, By Catheters (2020-2028) ($MN); Table 16 Global Interventional Cardiology Devices Market Outlook, By IVUS/OCT Catheters (2020-2028) ($MN); Table 17 Global Interventional Cardiology Devices Market Outlook, By Angiography Catheters (2020-2028) ($MN); Table 18 Global Interventional Cardiology Devices Market Outlook, By Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters (2020-2028) ($MN); Table 19 Global Interventional Cardiology Devices Market Outlook, By Hemodynamic Flow Alteration Devices (2020-2028) ($MN); Table 20 Global Interventional Cardiology Devices Market Outlook, By Chronic Total Occlusion Devices (2020-2028) ($MN); Table 21 Global Interventional Cardiology Devices Market Outlook, By Embolic Protection Devices (2020-2028) ($MN); Table 22 Global Interventional Cardiology Devices Market Outlook, By Angioplasty Ballons (2020-2028) ($MN); Table 23 Global Interventional Cardiology Devices Market Outlook, By Drug Eluting Ballons (2020-2028) ($MN); Table 24 Global Interventional Cardiology Devices Market Outlook, By Old/ Normal Ballons (2020-2028) ($MN); Table 25 Global Interventional Cardiology Devices Market Outlook, By Cutting & Scorimg Ballons (2020-2028) ($MN); Table 26 Global Interventional Cardiology Devices Market Outlook, By Plaque Modification Devices (2020-2028) ($MN); Table 27 Global Interventional Cardiology Devices Market Outlook, By Thrombectomy Devices (2020-2028) ($MN); Table 28 Global Interventional Cardiology Devices Market Outlook, By Atherectomy Devices (2020-2028) ($MN); Table 29 Global Interventional Cardiology Devices Market Outlook, By Inferior Vena Cava (IVC) Filters (2020-2028) ($MN); Table 30 Global Interventional Cardiology Devices Market Outlook, By Accessories (2020-2028) ($MN); Table 31 Global Interventional Cardiology Devices Market Outlook, By Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires (2020-2028) ($MN); Table 32 Global Interventional Cardiology Devices Market Outlook, By Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons (2020-2028) ($MN); Table 33 Global Interventional Cardiology Devices Market Outlook, By Other Devices (2020-2028) ($MN); Table 34 Global Interventional Cardiology Devices Market Outlook, By Ballon Inflation Devices (2020-2028) ($MN); Table 35 Global Interventional Cardiology Devices Market Outlook, By Vascular Closure Devices (2020-2028) ($MN); Table 36 Global Interventional Cardiology Devices Market Outlook, By Hemostasis Valves (2020-2028) ($MN); Table 37 Global Interventional Cardiology Devices Market Outlook, By Introducer Sheaths (2020-2028) ($MN); Table 38 Global Interventional Cardiology Devices Market Outlook, By Other Products (2020-2028) ($MN); Table 39 Global Interventional Cardiology Devices Market Outlook, By End User (2020-2028) ($MN); Table 40 Global Interventional Cardiology Devices Market Outlook, By Ambulatory Surgical Centers (2020-2028) ($MN); Table 41 Global Interventional Cardiology Devices Market Outlook, By Hospitals (2020-2028) ($MN); Table 42 Global Interventional Cardiology Devices Market Outlook, By Other End Users (2020-2028) ($MN); Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.